Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
J Virol. 2012 Sep;86(18):9802-16. doi: 10.1128/JVI.01165-12. Epub 2012 Jul 3.
HLA-B5701 is the host factor most strongly associated with slow HIV-1 disease progression, although rates can vary within this group. Underlying mechanisms are not fully understood but likely involve both immunological and virological dynamics. The present study investigated HIV-1 in vivo evolution and epitope-specific CD8(+) T cell responses in six HLA-B5701 patients who had not received antiretroviral treatment, monitored from early infection for up to 7 years. The subjects were classified as high-risk progressors (HRPs) or low-risk progressors (LRPs) based on baseline CD4(+) T cell counts. Dynamics of HIV-1 Gag p24 evolution and multifunctional CD8(+) T cell responses were evaluated by high-resolution phylogenetic analysis and polychromatic flow cytometry, respectively. In all subjects, substitutions occurred more frequently in flanking regions than in HLA-B5701-restricted epitopes. In LRPs, p24 sequence diversity was significantly lower; sequences exhibited a higher degree of homoplasy and more constrained mutational patterns than HRPs. The HIV-1 intrahost evolutionary rate was also lower in LRPs and followed a strict molecular clock, suggesting neutral genetic drift rather than positive selection. Additionally, polyfunctional CD8(+) T cell responses, particularly to TW10 and QW9 epitopes, were more robust in LRPs, who also showed significantly higher interleukin-2 (IL-2) production in early infection. Overall, the findings indicate that HLA-B5701 patients with higher CD4 counts at baseline have a lower risk of HIV-1 disease progression because of the interplay between specific HLA-linked immune responses and the rate and mode of viral evolution. The study highlights the power of a multidisciplinary approach, integrating high-resolution evolutionary and immunological data, to understand mechanisms underlying HIV-1 pathogenesis.
HLA-B5701 是与 HIV-1 疾病进展缓慢相关性最强的宿主因素,尽管在该群体中进展速度可能有所不同。其潜在机制尚未完全阐明,但可能涉及免疫和病毒学动态。本研究调查了六位未接受抗逆转录病毒治疗的 HLA-B5701 患者的 HIV-1 体内进化和表位特异性 CD8(+)T 细胞反应,这些患者从早期感染开始监测,最长达 7 年。根据基线 CD4(+)T 细胞计数,将受试者分为高危进展者(HRP)和低危进展者(LRP)。通过高分辨率系统进化分析和多色流式细胞术分别评估 HIV-1 Gag p24 进化和多功能 CD8(+)T 细胞反应的动力学。在所有受试者中,取代在侧翼区域比在 HLA-B5701 限制性表位中更频繁地发生。在 LRP 中,p24 序列多样性显著较低;序列表现出更高的同质性和更受限制的突变模式,而不是 HRP。LRP 中的 HIV-1 宿主内进化率也较低,遵循严格的分子钟,表明是中性遗传漂变而不是正选择。此外,多功能 CD8(+)T 细胞反应,特别是对 TW10 和 QW9 表位的反应,在 LRP 中更为强烈,这些患者在早期感染中也表现出显著更高的白细胞介素-2(IL-2)产生。总的来说,这些发现表明,基线时 CD4 计数较高的 HLA-B5701 患者 HIV-1 疾病进展的风险较低,这是由于特定的 HLA 相关免疫反应与病毒进化的速度和模式之间的相互作用所致。该研究强调了整合高分辨率进化和免疫数据的多学科方法的力量,以了解 HIV-1 发病机制的机制。